| scholarly article | Q13442814 |
| P2093 | author name string | Hack CE | |
| Nieuwland R | |||
| Sturk A | |||
| Böing AN | |||
| Berckmans RJ | |||
| Romijn FP | |||
| P433 | issue | 4 | |
| P304 | page(s) | 639-646 | |
| P577 | publication date | 2001-04-01 | |
| P1433 | published in | Thrombosis and Haemostasis | Q15724413 |
| P1476 | title | Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation | |
| P478 | volume | 85 |
| Q26786677 | "Soluble Tissue Factor" in the 21st Century: Definitions, Biochemistry, and Pathophysiological Role in Thrombus Formation |
| Q91655251 | A transmission electron microscopy study of anticoagulant-induced platelet vesiculation |
| Q31144359 | Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin |
| Q35590638 | Age- and sex-specific differences in blood-borne microvesicles from apparently healthy humans |
| Q40582473 | Aging- and activation-induced platelet microparticles suppress apoptosis in monocytic cells and differentially signal to proinflammatory mediator release |
| Q35625528 | Alterations in adhesion molecules, pro-inflammatory cytokines and cell-derived microparticles contribute to intima-media thickness and symptoms in postmenopausal women. |
| Q47651258 | Analysis of factor XIa, factor IXa and tissue factor activity in burn patients |
| Q35949830 | Are microparticles the missing link between thrombosis and autoimmune diseases? Involvement in selected rheumatologic diseases. |
| Q58576944 | Bariatric surgery reduces CD36-bearing microvesicles of endothelial and monocyte origin |
| Q35611763 | Biological properties of extracellular vesicles and their physiological functions. |
| Q40142535 | Bronchoalveolar Lavage Microvesicles Protect Burn-Injured Mice from Pulmonary Infection. |
| Q34284335 | CLEC-2 expression is maintained on activated platelets and on platelet microparticles. |
| Q37331535 | Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. |
| Q34442188 | Cause or effect of arteriogenesis: compositional alterations of microparticles from CAD patients undergoing external counterpulsation therapy |
| Q34160603 | Cellular microparticle and thrombogram phenotypes in the Prospective Observational Multicenter Major Trauma Transfusion (PROMMTT) study: correlation with coagulopathy |
| Q41512269 | Changes in the pattern of plasma extracellular vesicles after severe trauma |
| Q41167287 | Characterisation of tumour-derived microvesicles in cancer patients' blood and correlation with clinical outcome |
| Q36893365 | Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women |
| Q40041343 | Characterization of intravascular cellular activation in relationship to subclinical atherosclerosis in postmenopausal women |
| Q36144112 | Characterization of membrane-shed microvesicles from cytokine-stimulated β-cells using proteomics strategies |
| Q37004064 | Characterizing blood microparticles: technical aspects and challenges. |
| Q36346156 | Circulating Microparticles Alter Formation, Structure, and Properties of Fibrin Clots. |
| Q37539000 | Circulating contact-pathway-activating microparticles together with factors IXa and XIa induce spontaneous clotting in plasma of hematology and cardiologic patients |
| Q35212590 | Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers |
| Q37406776 | Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease |
| Q30754485 | Circulating levels of cell-derived microparticles are reduced by mild hypobaric hypoxia: data from a randomised controlled trial |
| Q34277653 | Circulating mesenchymal stem cells microparticles in patients with cerebrovascular disease |
| Q34476755 | Circulating microparticles and endogenous estrogen in newly menopausal women |
| Q47139699 | Circulating microparticles in acute diabetic Charcot foot exhibit a high content of inflammatory cytokines, and support monocyte-to-osteoclast cell induction |
| Q43157080 | Circulating microparticles, protein C, free protein S and endothelial vascular markers in children with sickle cell anaemia. |
| Q34680832 | Circulating microparticles: square the circle |
| Q37782534 | Clinical relevance of microparticles from platelets and megakaryocytes |
| Q26830846 | Clinical significance of procoagulant microparticles |
| Q33748551 | Comparative response of platelet fV and plasma fV to activated protein C and relevance to a model of acute traumatic coagulopathy |
| Q39270246 | Coordinate stimulation of macrophages by microparticles and TLR ligands induces foam cell formation |
| Q42094457 | Decline in platelet microparticles contributes to reduced hemostatic potential of stored plasma |
| Q41141303 | Different Potential of Extracellular Vesicles to Support Thrombin Generation: Contributions of Phosphatidylserine, Tissue Factor, and Cellular Origin |
| Q38905674 | Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. |
| Q50090311 | Dissecting the biochemical architecture and morphological release pathways of the human platelet extracellular vesiculome |
| Q37644081 | Do galectins play a role in venous thrombosis? a review. |
| Q53431937 | Effect of blood microparticles on the kinetics of polymerization and enzymatic hydrolysis of fibrin. |
| Q87346231 | Effect of oxygen-breathing during a decompression-stop on bubble-induced platelet activation after an open-sea air dive: oxygen-stop decompression |
| Q42174913 | Effects of Chronic Exercise on Endothelial Progenitor Cells and Microparticles in Professional Runners |
| Q38138876 | Emerging paradigms in arterial thrombosis |
| Q35489022 | Endothelial cell microparticles act as centers of matrix metalloproteinsase-2 (MMP-2) activation and vascular matrix remodeling |
| Q35227861 | Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation |
| Q90281882 | Evidence for Adipocyte-Derived Extracellular Vesicles in the Human Circulation |
| Q57166259 | Exercise-Derived Microvesicles: A Review of the Literature |
| Q34674369 | Expression of regulatory platelet microRNAs in patients with sickle cell disease |
| Q39107240 | Extracellular vesicles and blood diseases |
| Q39453434 | Extracellular vesicles in renal disease |
| Q52680357 | From blood coagulation to innate and adaptive immunity: the role of platelets in the physiology and pathology of autoimmune disorders. |
| Q38233155 | Global assays of hemostasis |
| Q60046250 | Human bone marrow contains high levels of extracellular vesicles with a tissue-specific subtype distribution |
| Q33726792 | Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function |
| Q52649288 | Identification of Novel Hemostatic Biomarkers of Adverse Clinical Events in Patients Implanted With a Continuous-Flow Left Ventricular Assist Device. |
| Q53822322 | Imbalance between endothelial damage and repair capacity in chronic obstructive pulmonary disease. |
| Q37316399 | Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases |
| Q26823258 | Inflammation and haemostasis |
| Q55346403 | Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab. |
| Q64884992 | Involvement of Extracellular Vesicles in Vascular-Related Functions in Cancer Progression and Metastasis. |
| Q40360154 | Isolation and Characterization of Microvesicles from Peripheral Blood |
| Q90219492 | Label-free identification and chemical characterisation of single extracellular vesicles and lipoproteins by synchronous Rayleigh and Raman scattering |
| Q60956629 | Large Extracellular Vesicles: Have We Found the Holy Grail of Inflammation? |
| Q33692623 | Loss of estrogen receptor beta decreases mitochondrial energetic potential and increases thrombogenicity of platelets in aged female mice |
| Q30485800 | Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles |
| Q30854772 | Membrane Ballooning in Aggregated Platelets is Synchronised and Mediates a Surge in Microvesiculation |
| Q52648131 | Membrane properties involved in calcium-stimulated microparticle release from the plasma membranes of S49 lymphoma cells. |
| Q35661078 | Methodology for isolation, identification and characterization of microvesicles in peripheral blood |
| Q38823688 | Microparticle of drug and nanoparticle: a biosynthetic route. |
| Q33386635 | Microparticle surface protein are associated with experimental venous thrombosis: a preliminary study |
| Q37112875 | Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects |
| Q37950250 | Microparticles and microRNAs: new players in the complex field of coagulation. |
| Q26783691 | Microparticles as Biomarkers of Blood Coagulation in Cancer |
| Q38334501 | Microparticles as potential biomarkers of cardiovascular disease |
| Q35269888 | Microparticles from apoptotic platelets promote resident macrophage differentiation. |
| Q35131040 | Microparticles in hemostasis and thrombosis. |
| Q47964479 | Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease. |
| Q34991385 | Microparticles provide a novel biomarker to predict severe clinical outcomes of dengue virus infection |
| Q41129291 | Microparticles: a new perspective in central nervous system disorders. |
| Q38242740 | Microparticles: new light shed on the understanding of venous thromboembolism. |
| Q26768704 | Microvesicles as a potential biomarker of neoplastic diseases and their role in development and progression of neoplasm |
| Q36635032 | Microvesicles as potential ovarian cancer biomarkers |
| Q57574568 | Microvesicles from platelets: novel drivers of vascular inflammation |
| Q49741768 | Microvesicles in Atherosclerosis and Angiogenesis: From Bench to Bedside and Reverse |
| Q26799753 | Molecular characterisation of plasma membrane-derived vesicles |
| Q35077960 | Multiple levels of degradation diminish hemostatic potential of thawed plasma |
| Q92563504 | Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium |
| Q55652396 | New players in haemostasis and thrombosis. |
| Q27023547 | On the origin of microparticles: From "platelet dust" to mediators of intercellular communication |
| Q37770447 | Pathophysiological role of blood-borne tissue factor: should the old paradigm be revisited? |
| Q35845083 | Phospholipid Binding Protein C Inhibitor (PCI) Is Present on Microparticles Generated In Vitro and In Vivo. |
| Q39637052 | Physical characterization of mouse deep vein thrombosis derived microparticles by differential filtration with nanopore filters |
| Q89456970 | Plasma mEV levels in Ghanain malaria patients with low parasitaemia are higher than those of healthy controls, raising the potential for parasite markers in mEVs as diagnostic targets |
| Q36570485 | Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice |
| Q61809495 | Platelet Reactivity And Circulating Platelet-Derived Microvesicles Are Differently Affected By P2Y Receptor Antagonists |
| Q58615766 | Platelet activity and hypercoagulation in type 2 diabetes |
| Q47106708 | Platelet-Derived Microvesicles in Cardiovascular Diseases. |
| Q36294191 | Platelet-independent adhesion of calcium-loaded erythrocytes to von Willebrand factor |
| Q24655248 | Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles |
| Q92106724 | Platelets in Skin Autoimmune Diseases |
| Q93092127 | Postprandial Increase in Blood Plasma Levels of Tissue Factor-Bearing (and Other) Microvesicles Measured by Flow Cytometry: Fact or Artifact? |
| Q35738647 | Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity. |
| Q37474995 | Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome |
| Q36804747 | Promoter polymorphisms in the ATP binding cassette transporter gene influence production of cell-derived microparticles and are highly associated with susceptibility to severe malaria in humans |
| Q42455347 | Proteomics of microparticles after deep venous thrombosis. |
| Q36370881 | Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation |
| Q35973634 | Quantification of hypercoagulable state after blunt trauma: microparticle and thrombin generation are increased relative to injury severity, while standard markers are not. |
| Q55257984 | Red Blood Cell Homeostasis: Mechanisms and Effects of Microvesicle Generation in Health and Disease. |
| Q24795283 | Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin |
| Q38386629 | Robust Label-free, Quantitative Profiling of Circulating Plasma Microparticle (MP) Associated Proteins |
| Q28069254 | Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis |
| Q50503112 | Role of zebrafish thrombocyte and non-thrombocyte microparticles in hemostasis. |
| Q36758718 | Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause |
| Q24816704 | Synovial microparticles from arthritic patients modulate chemokine and cytokine release by synoviocytes |
| Q54622130 | Temporal phenotyping of circulating microparticles after trauma: a prospective cohort study. |
| Q90600226 | The Exposure of Phosphatidylserine Influences Procoagulant Activity in Retinal Vein Occlusion by Microparticles, Blood Cells, and Endothelium |
| Q36898211 | The Gas6-Axl Protein Interaction Mediates Endothelial Uptake of Platelet Microparticles |
| Q47159100 | The Impact of Vascular Disease Treatment on Platelet-Derived Microvesicles |
| Q28066054 | The biology of extracellular vesicles with focus on platelet microparticles and their role in cancer development and progression |
| Q36070512 | The clinical and functional relevance of microparticles induced by activated protein C treatment in sepsis |
| Q33916623 | The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases |
| Q39646902 | The nature of the stable blood clot procoagulant activities |
| Q38250442 | The role of hemostasis in infective endocarditis |
| Q34360277 | The tissue factor requirement in blood coagulation |
| Q61814938 | Thrombin Generation and Cancer: Contributors and Consequences |
| Q36210410 | Thrombin generation and procoagulant microparticle profiles after acute trauma: A prospective cohort study. |
| Q37438302 | Tissue factor in coagulation: Which? Where? When? |
| Q37288296 | Tissue factor structure and function |
| Q90657275 | Type 2 diabetes and older age contribute to elevated plasma microparticle concentrations independent of chronic stroke |
| Q26784612 | Understanding the biosynthesis of platelets-derived extracellular vesicles |
| Q36072567 | Zebrafish thrombocytes: functions and origins |
| Q41558378 | β3 phosphorylation of platelet αIIbβ3 is crucial for stability of arterial thrombus and microparticle formation in vivo. |
Search more.